Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Immunome, Inc. (IMNM) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-53.84M |
|
-- |
|
-- |
|
$59.33M |
|
$-59.33M |
|
$5.49M |
|
$-53.84M |
|
$-53.84M |
|
$-53.84M |
|
$-53.84M |
|
$-53.84M |
|
$-53.84M |
|
$-59.33M |
|
$-58.58M |
|
113.14M |
|
113.14M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$594.31M |
|
$17.08M |
|
$25.48M |
|
$619.79M |
|
$27.41M |
|
-- |
|
$3.69M |
|
$31.11M |
|
$588.69M |
|
$588.69M |
|
$588.69M |
|
113.17M |
|
| Cash Flow Statement Financials | |
$-58.64M |
|
$-12.02M |
|
$-0.14M |
|
$653.69M |
|
$582.90M |
|
$-70.79M |
|
$7.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.68 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-61.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.15% |
|
-9.15% |
|
-8.69% |
|
-9.15% |
|
$5.20 |
|
$-0.54 |
|
$-0.52 |
|